glp 1 agonist in pregnancy Prenatal exposure to GLP-1 receptor agonists and other second-line antidiabetics may not pose greater risk to infants than insulin Continuing Glucagon-Like Peptide-1 Receptor Agonists

Reported reductions in SBP ranged from approximately 1 to 3 mm Hg

Smoking and hypertension as predictors of cardiovascular risk in population studies

Evidence from a multicenter, long-term cardiovascular outcome trial demonstrated that GLP-1RAs reduce mortality associated with cardiovascular disease and confer protective effects by decreasing the incidence of myocardial infarction and nonfatal stroke.104 GLP-1RAs have been shown to enhance endothelial cell function through anti-inflammatory and vasodilatory mechanisms

GLP1/GIP receptor agonists 3.2.1

Retatrutide has a half-life of approximately six days, which supports once-weekly dosing

Back Baden, A (14 May 2025) 'People who stop weight loss drugs return to original weight within year, analysis finds', The Guardian